Cytotoxic CD8-positive T-cell activation pathway (CD8+ T-cell activation pathway)

The cytotoxic CD8-positive T-cell activation pathway is a core component of the adaptive immune response, enabling CD8+ T cells (cytotoxic T lymphocytes, CTLs) to recognize antigenic peptides presented by MHC class I molecules, become activated, proliferate, and kill target cells via the release of cytotoxic mediators such as perforin and granzymes. This process requires multiple co-stimulatory signals and is tightly regulated both temporally and spatially[1][5][4][3]. Dysregulation of this pathway is implicated in a broad spectrum of diseases—including cancer, viral infections, and autoimmune conditions[3][2][4]. This pathway is not a druggable target per se, but is modulated by immunotherapies that influence the activity of constituent molecules and cells (e.g., checkpoint inhibition acts via this pathway rather than on it directly)[2][4][3]. Thus, for structured data extraction, most entries except description, aliases, and pathway classification would be considered incomplete or incorrect if expecting a single molecule/receptor.

Other names

Cytotoxic T lymphocyte activation pathwayCD8-positive T cell activation pathway

Enhancement of CD8+ T-cell cytotoxicity (e.g., checkpoint inhibition), blockade of suppressive signals, promotion of memory T-cell formation